It also inhibited HMGB1-mediated hyperpermeability and leukocyte migration in mice, reduced sepsis-related mortality and pulmonary injury when administered at 0.26 or 0.39 mg/kg i.v. (Lee et al., 2017a). This evidence concerns the gene HMGB1 and Sepsis.